Matthew Milowsky, MD

George Gabriel Villere Distinguished Professor of Bladder and Genitourinary Cancer Research
Section Chief of Genitourinary Oncology
Co-Director of Urologic Oncology Program

Specialty Areas

Urologic Oncology Program

Chronology

BA: University of Pennsylvania, 1991; MD: State University of New York (SUNY) Downstate College of Medicine, 1996; Resident: New England Medical Center—Tufts University School of Medicine, 1997-1999; Clinical Fellow in Hematology and Medical Oncology: New York Presbyterian Hospital—Weill Cornell Medical Center, 1999-2001; Chief Clinical Fellow in Hematology and Medical Oncology: New York Presbyterian Hospital—Weill Cornell Medical Center, 2001-2002; Visiting Associate Physician: The Rockefeller University Hospital, New York, NY, 2003-2004; Assistant Attending Physician: New York Presbyterian Hospital—Weill Cornell Medical Center, 2002-2006; Assistant Professor of Urology: Weill Cornell Medical College, New York, NY, 2002-2006; Assistant Professor of Medicine: Weill Cornell Medical College, New York, NY, 2002-2011; Assistant Attending Physician: Memorial Sloan-Kettering Cancer Center, New York, NY, 2006-2011; Assistant Member (Level II): Memorial Sloan-Kettering Cancer Center, New York, NY, 2006-2011; Associate Professor of Medicine: Division of Hematology/Oncology, Department of Medicine, University of North Carolina, 2011-2015; Clinical Associate Professor of Urology: Department of Urology, University of North Carolina, 2013-2015; Deputy Clinic Medical Director: North Carolina Cancer Hospital, 2013-2014; Clinic Medical Director: North Carolina Cancer Hospital, 2014-2017; Associate Professor of Medicine with Tenure: Division of Hematology/Oncology, Department of Medicine, University of North Carolina, 2015-2018; Clinical Associate Professor of Urology with Tenure: Department of Urology, University of North Carolina, 2015-2018; Member: UNC Lineberger Comprehensive Cancer Center, University of North Caroline, 2011-present; Co-Director: Urologic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Caroline, 2011-present; Section Chief: Genitourinary Oncology, Division of Hematology/Oncology, Department of Medicine, University of North Carolina, 2011-present; Professor of Medicine: Division of Hematology/Oncology, Department of Medicine, University of North Carolina, 2018-present; Clinical Professor of Urology: Department of Urology, University of North Carolina, 2018-present; Distinguished Professor of Medicine: The George Gabriel Villere Distinguished Professor of Bladder and Genitourinary Cancer Research, Division of Hematology/Oncology, Department of Medicine, University of North Carolina, 2018-present.

Research and Clinical Interests

Dr. Milowsky is a medical oncologist and clinical and translational researcher. His clinical interest is in the treatment of patients with genitourinary cancers, including bladder cancer, testicular cancer, kidney cancer, and prostate cancer. He is the Section Chief of the Genitourinary Oncology Service, and Co-Director of the Urologic Oncology Program.

Dr. Milowsky joined UNC to lead the Genitourinary Oncology Research Program with a focus on translational science and clinical trials for patients with urologic cancers. His research focuses on the development of novel therapies for patients with urologic malignancies. He has a particular interest in the design of clinical trials that utilize novel immunotherapies as well as those that use an integrated genomics approach to characterize genitourinary cancers for genetic alterations that may represent targets for novel agents.

View Publications